We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Could Require More Data on Generic Combo Products’ User Interfaces, Agency Document Says
FDA Could Require More Data on Generic Combo Products’ User Interfaces, Agency Document Says
In a new procedural document released on Wednesday, the FDA directs its Office of Generic Drugs (OGD) to request additional data from sponsors of generic combination products if the generic product’s user interface is substantially different from the original product.